WASHINGTON - The US Food and Drug Administration (FDA) is asking some of its recently fired scientists if they will come back ...

The FDA has announced that the shortage of Wegovy and Ozempic, medications used for weight loss and diabetes management, is ...

The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk’s popular weight-loss and ...

The U.S. Food and Drug Administration is asking some of its recently fired scientists if they will come back to their jobs, ...

The US foreign aid freeze causes disruption in the supply chain for vital medical products in poorer countries, affecting diseases like HIV and malaria. Other health updates include FDA drug approvals ...

The U.S. Food and Drug Administration is asking some of its recently fired scientists if they will come back to their jobs, ...

OS Therapies, Inc., a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, announced that it received a Notice of Allowance from the United ...

The U.S. Food and Drug Administration said Ozempic and Wegovy, the popular GLP-1 drugs for diabetes and weight loss, are no ...

Esperion Therapeutics has two approved LDL-C lowering therapies, Nexletol and Nexlizet, but lacks a strong pipeline for future growth.

We recently published a list of Five Chinese Firms Dominate Friday’s Top 10 Gainers. In this article, we are going to take a ...

REYKJAVIK, Iceland and PARSIPPANY, NJ, USA I1, 2025 I Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: ...

Sakhiya Skin Clinic, a pioneer in dermatology and aesthetic medicine in India, proudly introduces the Apollo Duet, an ...